All CLL patients were also analyzed for IGHV mutational status and CD38 expression; 35 patients (37.6%) displayed unmutated IGHV and 59 (62.8%) were mutated (with SHM greater or equal to 2% different from the germline V gene sequence). The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.